Commentary

0
0
0
s2sdefault

Lars Ramström | 25 November 2013

The revision of the EU Tobacco Products Directive raises some interesting issues regarding smokeless tobacco products (STP). In the Directive those oral STPs that are kept in the mouth (Swedish snus) are called ‘oral tobacco’, while those oral STPs that are chewed in the mouth are called ‘other STP’.

0
0
0
s2sdefault

Mirosław Dworniczak | 17 November 2013

From time to time e-cigarettes appear in the media. Unfortunately, they are usually still presented in a bad light. The usual arguments are as follows: we do not know exactly what's inside an e-cigarette, they are as poisonous as „the real ones”, there's no research concerning e-cigarettes. 

0
0
0
s2sdefault

Clive Bates | 17 November 2013

The investment analysts are always interesting on tobacco and e-cigs, and in a usefully dispassionate ‘follow-the-money’ kind of way.

Here’s a small collection of quotes I’ve seen in recent analyst reports mainly as they relate to regulation of e-cigarettes. I don’t see all reports of course so this is necessarily selective.

0
0
0
s2sdefault

Marcel Göertz | 10 November 2013

A couple of months ago, e-cigarette users from the Dutch speaking part of Belgium and the Netherlands joined hands and formed a group of activist vapers. Acvoda - Actie Comité voor Dampers (Action Committee for Vapers) - was born. While this seems a logical unison, the fact is that the current situation for Dutch e-cigarette users is completely different than the situation for the Belgian users.

0
0
0
s2sdefault

Suzi Gage | 02 November 2013

The tobacco industry has been shown to mislead with its research, but is forcing it to become more hidden a better option? Last week, the BMJ announced that it was finally implementing a practice that it had been discussing since the mid 1990s. Research partly or fully funded by the tobacco industry will no longer be published in BMJ, BMJ Open, Thorax and Heart. 

0
0
0
s2sdefault

Clive Bates | 16 October 2013

On 8th October in Strasbourg, the European Parliament voted on a raft of measures to regulate tobacco and nicotine products. The headlines were the following [also see Telegraph summary]:

  • a ban on menthol and other flavoured cigarettes from 2022
  • warnings covering 65% of packs (30% now – campaigners are pushing for 75% and the right to go further)
  • a ban on selling cigarettes in packs of less than 20
  • no ban on ‘slim’ cigarettes
  • a ban on most additives in tobacco products
  • a continuation of the ban on snus outside Sweden in the face of all evidence.

0
0
0
s2sdefault

Gerry Stimson | 13 October 2013

As the Telegraph put it, ‘The decision by MEPs to reject a European Commission proposal to treat electronic cigarettes as medicinal products was as sensible as it was unexpected’.

 

0
0
0
s2sdefault

Konstantinos Farsalinos | 04 October 2013

I am sure everyone has heard the “magic number”: 60mg is the nicotine lethal dose in adults. Τhis is a very low level, which would categorize nicotine as one of the most toxic substances available. It is a very common and strong argument of the regulatory authorities and of several anti-smokers activists who support very strict regulation on e-cigarettes and criticize the high levels of nicotine present mostly in refillable liquid bottles.

0
0
0
s2sdefault

Clive Bates | 03 October 2013

The amendment number 170 on e-cigarettes [ here] is now published and ready for consideration by the European Parliament on 8 October. As this was circulating on Monday 30th Sept, I wrote with comments and advice to the MEPs negotiating the amendment. Given they ignored most of it (!) that, these comments and the advice can now be read as concerns and criticisms. 

0
0
0
s2sdefault

Gerry Stimson | 29 September 2013

What were they thinking of at the European Commission when they proposed continuing with the ban on snus? The ban, and the proposal to control e-cigarettes as medicines, ranks as public health folly of the highest order.